Efficacy and safety of different Janus kinase inhibitors combined with methotrexate for the treatment of rheumatoid arthritis: a single-center randomized trial

Abstract Objective To compare the efficacy and safety between baricitinib (BARI) and tofacitinib (TOFA) for the treatment of the rheumatoid arthritis (RA) patients receiving methotrexate (MTX) in clinical practice. Methods This retrospective study recruited 179 RA patients treated with BARI (2–4 mg/...

Descripció completa

Dades bibliogràfiques

Autors principals:	Xiaoling Liao, Wang Huo, Wen Zeng, Fang Qin, Fei Dong, Wanling Wei, Ling Lei
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2023-10-01
Col·lecció:	Advances in Rheumatology
Matèries:	Rheumatoid arthritis Baricitinib Tofacitinib Janus kinase (JAK) inhibitors Disease Activity Scale-28 (DAS-28)
Accés en línia:	https://doi.org/10.1186/s42358-023-00331-1
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!